We conduct research in all areas—physiology, biochemistry, basic science, and imaging—making this the most progressive program in the country. Yale School of Medicine and Yale New Haven Hospital are participating in a multi-center, FDA-approved feasibility clinical investigation of a responsive brain neurostimulator device for the treatment of epilepsy. The neurostimulator is designed to detect seizures in patients with epilepsy and to deliver mild electrical stimulation to suppress seizures before the patient has any symptoms. And Yale is part of a multi-institution consortium testing triggered deep-brain stimulation, a new approach to treating uncontrolled epilepsy.
Visit yalestudies.org to view available clinical trials or learn more about clinical research at Yale.